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Background: Although two-dimensional (2-D) monolayer cell cultures provide important information on basic
tumor biology and radiobiology, they are not representative of the complexity of three-dimensional (3-D) solid tu-
mors. In particular, new models reproducing clinical conditions as closely as possible are needed for radiobiological
studies to provide information that can be translated from bench to bedside.
Methods: We developed a novel system for the irradiation, under sterile conditions, of 3-D tumor spheroids, the
in vitro model considered as a bridge between the complex architectural organization of in vivo tumors and the
very simple one of in vitro monolayer cell cultures. The system exploits the same equipment as that used for patient
treatments, without the need for dedicated and highly expensive instruments. To mimic the passage of radiation
beams through human tissues before they reach the target tumor mass, 96-multiwell plates containing the multicel-
lular tumor spheroids (MCTS) are inserted into a custom-built phantom made of plexiglass, the material most similar
to water, the main component of human tissue.
Results: The system was used to irradiate CAEP- and A549-derived MCTS, pre-treated or not with 20 μM cisplatin,
with a dose of 20 Gy delivered in one session. We also tested the same treatment schemes on monolayer CAEP
and A549 cells. Our preliminary results indicated a significant increment in radiotoxicity 20 days after the end of
irradiation in the CAEP spheroids pre-treated with cisplatin compared to those treated with cisplatin or irradiation
alone. Conversely, the effect of the radio- chemotherapy combination in A549-derived MCTS was similar to that
induced by cisplatin or irradiation alone. Finally, the 20 Gy dose did not affect cell survival in monolayer CAEP
and A549 cells, whereas cisplatin or cisplatin plus radiation caused 100% cell death, regardless of the type of
cell line used.
Conclusions: We set up a system for the irradiation, under sterile conditions, of tumor cells grown in 3-D which
allows for the use of the same dose intensities and schedules utilized in clinical practice. This irradiation system,
coupled with 3-D cell cultures, has the potential to generate information that could be used to individually
tailor radiotherapy.
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The irradiation of any biological system generates a suc-
cession of processes that can be grouped into physical,
physical-chemical and biological phases, all characterized
by specific events occurring at different times. The princi-
pal task of radiobiology is to analyze the effects that may
occur in the weeks, months and years after radiotherapy
and propose improvements to current therapies.
In recent years, researchers have focused on molecular
mechanisms triggered by irradiation which could help
cells to escape death. Such studies are key to obtaining
information on potential molecular targets for the set-
ting up of novel radiosensitization approaches or for the
design of mathematical algorithms suitable for tailoring
radiotherapy [1]. It is also crucial for scientists working
in this specific research area to carry out experiments on
in vitro biological models that are capable of reprodu-
cing and mimicking clinical conditions.
Although human tumor cell lines grown in monolayer
are mainly used for research and provide important infor-
mation on basic tumor biology and radiobiology, they can-
not be considered as fully representative of clinical
tumors. Multicellular tumor spheroids (MCTS) have a
three-dimensional architectural organization in which the
tumor cells are not uniformly exposed to nutrients and
oxygen, a condition that closely mimics the organization
of human tumors. Indeed, the potential of three-
dimensional (3-D) cell cultures for new anti-cancer thera-
peutic strategies is gaining recognition and is believed to
improve the pre-animal and pre-clinical selection of the
most promising treatment modalities [2-6].
The present work describes an in vitro irradiation sys-
tem for radiobiological experiments that closely resem-
bles clinical conditions and overcomes problems relating
to spheroid irradiation under sterile conditions.
Methods
Cell line
CAEP cells, derived from a squamous carcinoma of the
lung, were isolated and established in our laboratory, as
previously described [7]. A549, a commercially available
cell line derived from primary lung cancer, was obtained
from the American Type Culture Collection (ATCC,
Rockville, MD). Before seeding in the bioreactor culture
vessels, cells were expanded and maintained as a mono-
layer at 37°C and subcultured weekly. Culture medium
for the CAEP cells was composed of DMEM/HAM
F12 (1:1) supplemented with fetal calf serum (10%),
glutamine (2 mM) (Euroclone, Milan, Italy) and insu-
lin (10 g/ml) (Sigma Aldrich, Milan, Italy). A549 cells
were maintained in Ham's F12K (ATCC) supple-
mented with 10% FBS (Euroclone). The same culture
media used for the monolayer cultures were used to
grow the cells as MCTS.Three-dimensional cell culture bioreactor
A rotatory cell culture system (RCCS) (Synthecon,
Houston, TX, USA) was used [8]. The rotator bases were
placed inside a humidified 37°C, 5% CO2 incubator and
connected to power supplies set up externally to the in-
cubator. Culture vessels (50 mL) with a membrane that
allows gas exchange were used. Vessels were rinsed in
sterile PBS before all experiments. All procedures were
performed in sterile conditions under a laminar flow
hood. As no specific medium formulation was required
for cell growth in the RCCS, we used the same medium
as that utilized for the monolayer cell culture.
Single cell suspensions of about 1 × 106 cells/ml were
placed in the 50-mL rotating chamber at an initial speed
of 10 rpm. As the majority of cells formed aggregates
and these aggregates gradually enlarged, speed was in-
creased over time to avoid aggregate sedimentation
within the culture vessels which could hinder complete
spheroid formation. The culture medium was changed
every 4 days and tumor spheroids with a diameter ran-
ging from about 700 μm to 1.3 mm (depending on the
cell line used) were obtained in 15–20 days (Figure 1).
Drug treatment
Cisplatin was freshly diluted in standard medium at a
final concentration of 20 μM immediately before use. In
particular, spheroids were treated by replacing 50% of
the supernatant with cisplatin-supplemented standard
medium using a manual 8-channel pipette. In parallel,
spent medium from untreated reference spheroids was
replaced with fresh drug-free standard medium.
Irradiation system
At the time of irradiation, the operator, working under the
sterile laminar flow hood, transferred homogeneously-
sized spheroids treated or not with cisplatin 20 μM to
low-attachment 96-multiwell plates (one spheroid/well),
each well previously filled with 200 μl of fresh culture
medium (Figure 2a). The 96-multiwell plates containing
the MCTS were inserted into a custom built plexiglass
phantom (40 × 40 × 8 cm) (Figure 2b) composed of two
slabs of equal size (40 × 40 × 4 cm) in which a central re-
cess has been created at the radiation isocenter to house
the microtiter plate and irradiated in a single dose of
20 Gy (delivered over about four minutes).
The same plexiglass phantom was used for the irradi-
ation of 96-multiwell plates containing the cells grown
as monolayers and exposed or not to cisplatin 20 μM.
The phantom was irradiated using a 6-MV photon
beam delivered by an Elekta Synergy linear acceler-
ator (Elekta Oncology Systems, Stockholm, Sweden)
(Figure 2c), the same machine used on a daily basis
to deliver radiotherapy to patients and periodically
subject to specific quality assurance checks.
Figure 1 Three-dimensional cell cultures. (a) MCTS growing in 50-mL vessels installed into the RCCS. Representative image of CAEP grown as
(b, c) MCTS of about 1.3 -1.5 mm ∅ sampled from about 100 spherical colonies obtained from a single vessel or grown as (d, e) monolayer
cultures with normal bright-field or phase contrast respectively, obtained by Olympus inverted microscope with attached Nikon high speed
DS-Vi1 color digital camera. Spheroid number and size were determined through image analysis using NIS-Elements D software package.
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20×20 cm2 defined at the machine isocenter of 100 cm
from the source) were used to deliver a single dose of
20 Gy (Figure 3a,b) at the isocenter located at the centre
of the recess containing the microtiter plate or the flasks
(Figure 3c). The delivered dose was calculated using the
Philips Pinnacle 3 radiation therapy planning system
(Philips Healthcare, DA Best, The Netherlands) custom-
ized with the geometric and dosimetric characteristics of
an Elekta Synergy linear accelerator. In particular, the
dose distribution was calculated on a CT data-set of
the water-equivalent phantom previously scanned on a
Philips Brillance BigBore CT (Figure 3c). The resulting
treatment plan showed an excellent calculated dose uni-
formity in the plexiglass phantom irradiated with two
opposing beams, and the 6-MV photon energy ensured
perfect equivalence between plexiglass and water (the
main component of human soft tissue), as shown by the
dosimetric evaluation.
Calibrated radiochromic EBT3+ films (Gafchromic
EBT Films, International Specialty Products, Wayne, NJ,
USA) were used to verify the exactness of dose depos-
ition calculated by treatment planning system (TPS)Pinnacle 3. The radiochromic films were cut and placed
above (surface source distance [SSD] 99 cm) and below
the plate (SSD 101 cm) to record the planar dose depos-
ition. The two pieces of film were irradiated with an
open beam of 20 × 20 cm in anteroposterior (AP; film at
SSD 101 cm) and posteroanterior (PA; film at SSD
99 cm) configuration and scanned after 16 h using an
EPSON Expression 10000XL flat bed scanner (Epson,
Milan, Italy). The net optical density (netOD) was con-
verted to dose with home-made MATLAB software
(DoseTool5) using the formalism described by Devic
et al. [9]. The comparison performed with the open
source DoseLab 4.00 (http://doselab.sf.net) between the
TPS calculated dose and the radiochromic measured
dose showed good, uniform agreement resulting in a
gamma distribution image (Dose/Distance criteria of
5%/5 mm) with 98.4% (at SSD 99 cm) and 97.8% (at
SSD 101 cm) of pixels passing the gamma test.
A comparison between the calculated and measured
planar doses at SSD 99 cm is shown in Figure 4.
A comparison between the mass attenuation coeffi-
cient (red line) and the mass energy-absorption coeffi-
cient (black line) for plexiglass (dotted line) and water
Figure 2 Irradiation system. (a) Multiwell microplate containing the MCTS ready for in vitro testing. The spheroids were seeded into low-
attachment multiwell plates containing fresh medium alone or supplemented with 20 μM of cisplatin. The medium was removed and substituted
with 250 μl of fresh culture medium after a 72-h continuous exposure and the plates were once again placed in a CO2 incubator at 37°C for
20 days during which time medium was changed daily. (b, c) Plexiglass phantom containing a microtiter plate was positioned on the treatment
couch of the Elekta Synergy platform, the same machine used in daily clinical practice for the radiotherapeutic treatment of patients and
periodically subject to specific quality assurance checks.
Tesei et al. Radiation Oncology 2013, 8:257 Page 4 of 12
http://www.ro-journal.com/content/8/1/257
Figure 3 Treatment planning for cell culture irradiation. (a, b) Screenshot showing the source-axis distance (SAD), the dimensions of the par-
allel opposed fields and the target coverage used for MCTS irradiation. The SAD measured 100 cm, while the source surface distance (SSD) was
96 cm. (c) A CT scan was performed in the set-up phase of the phantom containing the microplate (in which wells were filled with culture
medium) in order to optimize dose delivery, exactly as would be done for a patient. Two opposed fields (AP at 0° and PA at 180°) of 20x20 cm2
were chosen for irradiation. The irradiation system, independently of dose, ensured the delivery of a uniform dose to the yellow areas containing
the microplate. A Philips Pinnacle3 radiation therapy planning system (Philips Healthcare) was used and customized with the geometric and dosi-
metric characteristics of an Elekta Synergy linear accelerator.
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in Figure 5. The plots for the two materials are superim-
posable in the range of energy of interest.
At the end of irradiation, the multiwell plates contain-
ing irradiated or cisplatin-treated and irradiated (2 Gy)
spheroids were placed in a CO2 incubator at 37°C for
20 days during which time medium was changed daily.
Histological staining and immunohistochemistry
Before hematoxylin and eosin staining, the cells, grown
as monolayers on a Lab-Tek® Chamber Slide™ System
(Nalge Nunc International, Rochester, NY, USA), were
directly fixed on the slide with 10% buffered formalin.
Histological staining was also performed on serial sec-
tions obtained from tumor spheres, included in colla-
gen (StemCell Technologies), fixed in 10% buffered
formalin and embedded in paraffin. Five-micrometer-
thick sections were stained with hematoxylin and eosinfor (morphological) photomicroscope (Zeiss, Axioscope
40) evaluation.
For the immunohistochemical determinations, anti-
cleaved caspase 3 (diluted 1:200) and anti-HMGB-1 (di-
luted 1:400) antibodies (Cell Signaling Technology Inc.,
Celbio, Milan, Italy) were used. Tissue sections were
treated with epitope retrieval solution [0.01 mol/L citrate
buffer (pH 6.0)] in a water bath at 98.5°C for 40 min
followed by a 20-min cooling period at room temperature.
An anti-rabbit secondary antibody (Bond Polymer Refine,
Leica Biosystems, Milan, Italy) was used to detect the pri-
mary antibodies. Cells were analyzed with a Zeiss Imager
M1 microscope (Milan, Italy) and the images were re-
corded using a Zeiss AxioVision camera (Milan, Italy).
Transmission electron microscopy
CAEP cells grown as monolayers or as MCTS were fixed
in 2.5% glutaraldehyde in 0.1 M phosphate buffer for 2 h
Figure 4 Dosimetric evaluation of calculated and measured dose distributions. (a) Comparison between the calculated and measured dose
inside the recess holding the microplate at SSD 99 cm, evaluated using radiochromic films (Gafchromic EBT Films, International Specialty
Products). (b) Planar distribution of gamma index representing the 98.4 pixels passing the test with dose tolerance of 5%. (c, d) Comparison
between measured (red line) and calculated (blue line) dose profiles along the short and the long side, respectively, of the cut Gafchromic film.
All images were created by Open Source DoseLab 4.00 software (http://doselab.sf.net).
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buffer for 1 h at 4°C. Subsequently, samples were dehy-
drated in a graded series of ethanol and embedded in
Epon resin (Sigma Aldrich, St. Louis, MS, USA). Ultra-
thin sections were counterstained with uranyl acetate
and lead citrate and observed under a Philips CM10
electron microscope (FEI Company, Eindhoven, The
Netherlands). Images were digitally captured by SIS
Megaview III CCD camera (FEI Company, Eindhoven,
The Netherlands).
Determination of cell viability
Cell growth was evaluated by acid phosphatase (APH)
assay [10], which has been shown to correlate with the
viability of cells both composing the spheroids and
grown as monolayers. Briefly (working under the lam-
inar flow hood), homogeneously-sized tumor spheroids
were selected after microscope observation and collected
singly using a micropipette whose tip had been removedby a sterile scalpel. The MCTS were then plated at a
density of 1.0 spheroid/well in ultralow-attachment 96-
well flat-bottom plates (Corning Inc., Corning, NY,
USA) to prevent their adhesion to the bottom of the
wells. Plates containing MCTS were then immediately
exposed to 20 μM of cisplatin for 72 h or to 20 Gy of ra-
diation singly or in sequence (20 μM of cisplatin for
72 h followed by irradiation at 20 Gy) and washed twice
by centrifugation (10 min at 400 g), after which the
medium culture was replaced by H2O DEPC. Wells were
supplemented with 100 μl of APH buffer solution (0.1 M
sodium acetate, 0.1% TRITON X-100 and 10 mg of p-
nitrophenyl phosphate freshly prepared before use) and
incubated for 90 min at 37°C, after which 10 μl of NaOH
were added to each well. Optical density of the samples
was determined at a wavelength of 405 nm using a spec-
trophotometer plate reader. Eight-sixteen spheroids were
analyzed for each treatment modality and experiments
were repeated twice.
Figure 5 Calculation of linear attenuation coefficient of water and plexiglass. Comparison between the mass attenuation coefficient (red
line) and the mass energy-absorption coefficient (black line) for plexiglass (dotted line) and water (solid line) as a function of the photon energy;
μ/ρ =mass attenuation coefficient (for plexiglass or water), μen/ρ =mass energy-absorption coefficient (for plexiglass or water); the data used for
the construction of the graph are available online at http://www.nist.gov/pml/data/xraycoef/index.cfm.
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Results were presented as the mean of at least 2 separate
experiments. Statistical differences were evaluated by the
Student’s t-test. Dose response curves were created by
Excel software. Differences among values observed after
the various treatments were analyzed using the Student’s
t-test for unpaired observations. A P value < 0.05 was
considered significant.
Results
A bioreactor developed at NASA [8] (Figure 1a) was
used to grow MCTS starting from single cell suspen-
sions derived from established human cancer cell lines
(Figure 1b-e). The pathophysiological features of solid
tumors (necrosis, apoptosis, dermal junctions and mi-
tosis) in the MCTS sections stained with hematoxylin
and eosin are shown in Figure 6 a,b. In particular, areas
of necrotic debris characterized by hypereosinophilia
and spherical-shaped apoptotic bodies showing a loss of
contact with the adjacent cells were detected. The chro-
matin of these cells was degraded and condensed, giving
the nucleus a heterochromatic appearance. The simul-
taneous presence of apoptotic bodies and necrosis was
confirmed by immunohistochemical analysis using spe-
cific antibodies against cleaved caspase 3 and the protein
HMGB1 (Additional file 1: Figure S1), respectively.Finally, structures that could be equated with the pres-
ence of dermal junctions, normally present in tissue be-
tween adjacent cells, were observed. These features were
no longer visible when the same cells were grown as
monolayers. Under such conditions, numerous mitotic
figures randomly distributed alongside large cells with
eosinophilic cytoplasm and polymorphic nuclei were ob-
served (Figure 6c,d).
In addition, ultrastructural electron microscopy ana-
lysis revealed features present in human lung tissue,
such as desmosomes, confirming what hematoxylin and
eosin staining had highlighted, and lipid clusters [11-13]
(Figure 7a,b). Such structures were not observed in
monolayer cultures of established tumor cell lines, as
confirmed by the electron microscopy image of mono-
layer CAEP cells that showed polygonal shaped cells
with no detectable desmosomes and only a few lipid
clusters in the cytoplasm (Figure 7c).
In the present paper we report preliminary results
after a 20 Gy irradiation of CAEP- and A549–derived
MCTS pretreated or not with 20 μM cisplatin (Figure 8).
Results were compared with those obtained after the
same treatments in cell lines grown as monolayers. The
cell growth of MCTS was analyzed over a 20-day period
and different effects were observed in relation to the cell
line type used. In particular, in CAEP-derived MCTS,
Figure 6 Histological staining of cells grown as three-dimensional colonies and monolayers. (a, b) Representative images of sections of
CAEP-derived MCTS stained with hematoxylin and eosin showing pathophysiological features of solid tumors (necrosis, apoptosis, dermal junc-
tions and mitosis). Histological staining was performed on sections obtained from tumor spheres that were included in collagen (StemCell Tech-
nologies) after 15 days of culture, fixed in 10% buffered formalin and embedded in paraffin. (c, d) Hematoxylin-eosin staining of CAEP cells
grown on the Lab-Tek® Chamber Slide™ System (Nalge Nunc International). Before staining, cells were directly fixed on the slide with 10% buff-
ered formalin. Photomicroscope analysis was performed using Axioscope 40 microscope (Zeiss, Milan Italy).
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pendently of the type of treatment used (Figure 8a). Fur-
thermore, a significant increase in radiotoxicity was
observed 20 days after the end of irradiation in the
spheroids pre-treated with cisplatin compared to those
treated with cisplatin or irradiation alone. Conversely, al-
though the growth of A549-derived MCTS was initially
strongly hampered by the combined radio-chemotherapy
treatment, at the end of the 20-day period such inhib-
ition was similar to that induced by cisplatin or irradi-
ation alone (Figure 8b).
We also tested the same treatment schemes on mono-
layer CAEP and A549 cells (Figure 8c,d), analyzing cell
growth over a 7-day period. Notably, the duration of the
experiment was significantly shorter than that used for
3-D cultures because the cells reached confluence aboutseven days after the end of treatment, showing cell-cell
contact inhibition and a consequent growth arrest.
Under such conditions, the different treatments tested
induced the same effect independently of the type of cell
line used. In particular, while 20 Gy of radiation in a sin-
gle dose did not influence cell growth, both cisplatin
alone and cisplatin plus 20 Gy radiation caused 100%
cell death.
Discussion
Although the use of tumor cell lines grown in monolayer
provides very important information on basic tumor
biology and radiobiology, it does not fully represent clin-
ical tumors. In particular, compared to cells cultured on
a flat surface, 3-D cell culture techniques better mimic
the natural environments of tissues and organs, where
Figure 7 Transmission electron microscope micrographs. (a, b). Representative images of 15-day-old CAEP spheroids showing features
present in human lung tissue, such as desmosomes and lipid clusters. (c) Electron microscopy image of CAEP cells grown as monolayers. 1 × 104
CAEP cells were seeded on glass slides, washed with PBS and processed as previously described in the Methods section.
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Figure 8 APH assay performed on MCTS (a, b) and monolayer cell cultures (c, d) derived from human epidermoid (CAEP) and
adenocarcinoma (A549) lung cancer cell lines. The cells were treated as follows; untreated ( ; Ctr), exposed to cisplatin 20 μM ( ; cis 20)
for 72 h, irradiated with 20 Gy ( ; 20 Gy) delivered in about 4 minutes, or exposed to 72-h cisplatin 20 μM followed by irradiation with 20 Gy
( ; radio + cis20). *P >0.05.
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cell and cell-matrix interactions and complex transport
dynamics for nutrients and cells [14,15]. Furthermore,
tumor spheroids show a three-dimensional organization
in which cells are not uniformly exposed to oxygen or
nutrients, which is more representative of the organization
of human tumors consisting of regions of regularly divid-
ing cells, hypoxic cells, and necrosis [6,16]. Conversely,
monolayer cultures consist of cells generally growing in a
nutrient rich liquid environment or on an agar surface
with an ample supply of oxygen, which form a virtually
homogeneous colony.
In the present study, MCTS were grown using a bio-
reactor developed at NASA [8] which exploits the low
force of gravity to assemble tumor cells and, importantly,offers the advantage compared to other systems (soft
agar, liquid overlay, hanging drop, etc.) of producing a
large amount of homogeneously-sized spheroids. In par-
ticular, the MCTS obtained using this approach exhibit
growth characteristics and pathophysiological features of
avascular tumor nodules and also of peripheral tumor
microregions near blood capillaries [6]. Furthermore, it
must be underlined that the MCTS experimental model
permits several analytical investigations in whole (growth
kinetics, histology, immune cell infiltration capacity and
cell mediated cytotoxicity) or dissociated spheroids (mo-
lecular analysis, re-growth analysis, clonogenic assay, flow
cytometry, biochemical assay) to be performed at baseline
or after radiation treatment. Several studies have shown
that cancer cells grown in a 3-D culture survive low doses
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cidal in the same cells grown in a two-dimensional (2-D)
culture [6,17]. Our preliminary results highlighted differ-
ences in terms of chemo- or radiosensitivity of the two cell
lines grown as 3-D spheroidal colonies after a 20-day ob-
servation, a culture time that cannot be reached by 2-D
cultures (maximum 7–8 days).
In the present work we also described how we resolved
some of the problems relating to irradiation of the cells
(the same system used for MCTS can be used to irradi-
ate flasks or plates containing cell cultures grown as
monolayer) under sterile conditions. For example, some
authors place the cell-containing plates or flasks,
wrapped in cling-film and tape, in basins filled with
water to simulate the passing of radiation through tis-
sues. These experimental conditions run the risk of
water infiltration which could compromise the sterile
conditions. We, on the other hand, inserted the 96-
multiwell plates or the flasks containing the cells into a
custom-built plexiglass phantom. Plexiglass was chosen
because, from a physical point of view, in terms of inter-
action with radiation, it is the material most similar to
water, the main component of human tissues passed
through by radiation beams before reaching the target
tumor mass. Furthermore, the recess within the plexi-
glass slabs was tailored for spheroid-containing micro-
plates and used in our experiments to minimize the
interfaces of different density between the plexiglass
walls and that of the microplate itself. In this way, the
plate containing the spheroids was closed inside the
plexiglass chamber by its lid, thus avoiding further
manipulations and the risk of water infiltration. This
system also guarantees irradiation of the 3-D or 2-D
cultures with complete coverage of the target utilizing
the same equipment and calculation methods used for
the planning of patient/treatments, without the need
for dedicated or highly expensive instruments and dosi-
metric verification for each experiment. Furthermore,
the duration of dose delivery ranges from a few seconds
to a few minutes, which does not influence cell sur-
vival. We are thus able to perform experiments with
both conventional fractionation and hypofractionation
regimens using the same procedures and timing as
routine clinical practice, resulting in a more realistic
evaluation of the cellular and biomolecular effect of ra-
diation therapy.
Conclusion
We believe that the novel system and biological model
proposed represents an important experimental ap-
proach for researchers working in the area of radiobiol-
ogy that could deepen our understanding of the basic
mechanisms of tumor radiobiology and help to improve
clinical treatment modalities.Additional file
Additional file 1: Figure S1. Immunohistochemical (IHC) detection of
apoptotic and necrotic cells. (a) Representative image showing
cytoplasmic and perinuclear localization of cleaved caspase 3 in
apoptotic cells (low and high magnification) using a specific anti-cleaved
caspase 3 antibody. (b) IHC staining for cellular necrosis using a primary
anti HMGB1 protein antibody. Notably, in this case positivity was localized
in the central area of the spherule, which was composed mainly of
cellular debris. Both IHC stains were performed on paraffin-embedded
CAEP tumor spheres using primary antibodies and detected with Bond
Polymer Refine detection system (Leica Biosystems).
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